-
Signature
-
/s/ Shelley Thunen, as Attorney-in-Fact
-
Stock symbol
-
RXST
-
Transactions as of
-
Feb 1, 2024
-
Transactions value $
-
-$214,230
-
Form type
-
4
-
Date filed
-
2/2/2024, 04:47 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RXST |
Common Stock |
Options Exercise |
$124K |
+6.54K |
+24.7% |
$18.90 |
33K |
Feb 1, 2024 |
Direct |
|
| transaction |
RXST |
Common Stock |
Options Exercise |
$13.6K |
+590 |
+1.79% |
$23.04 |
33.6K |
Feb 1, 2024 |
Direct |
|
| transaction |
RXST |
Common Stock |
Sale |
-$173K |
-3.54K |
-10.53% |
$49.00 |
30.1K |
Feb 1, 2024 |
Direct |
F1 |
| transaction |
RXST |
Common Stock |
Sale |
-$149K |
-3K |
-9.98% |
$49.50 |
27.1K |
Feb 1, 2024 |
Direct |
F1 |
| transaction |
RXST |
Common Stock |
Sale |
-$29.5K |
-590 |
-2.18% |
$50.00 |
26.5K |
Feb 1, 2024 |
Direct |
F1 |
| holding |
RXST |
Common Stock |
|
|
|
|
|
1.37K |
Feb 1, 2024 |
By spouse |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RXST |
Stock Option (right to buy) |
Options Exercise |
$0 |
-6.54K |
-45.03% |
$0.00 |
7.98K |
Feb 1, 2024 |
Common Stock |
6.54K |
$18.90 |
Direct |
|
| transaction |
RXST |
Stock Option (right to buy) |
Options Exercise |
$0 |
-590 |
-1.93% |
$0.00 |
30K |
Feb 1, 2024 |
Common Stock |
590 |
$23.04 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: